RSS

Novozymes Biopharma

Novozymes Biopharma, part of Novozymes A/S, announced that an ophthalmic solution made using its recombinant human albumin has been approved for Phase I/II development by the FDA. more

Technology

Novozymes Biopharma, part of Novozymes A/S, has introduced a new brand and visual identity for its recombinant human albumin (rAlbumin) portfolio. As part of the rebrand, Novozymes will... more

Technology